Changes in Pathological Complete Response Rates after Neoadjuvant Chemotherapy for Breast Carcinoma over Five Years

Table 3

Multivariate logistic regression model examining predictors of pathological complete response among female breast cancer patients treated with neoadjuvant chemotherapy ().

Variable	(SE)	OR	Sig	95% CI
				Lower	Upper
Hormone receptor positive only	−0.531 (0.74)	0.486	0.588	0.139	2.492
HER2+	0.809 (0.66)	2.247	0.223	0.611	8.259
Time period (after 12/2013)	1.379 (0.63)	3.97	0.03	1.146	13.753
Regimen (standard)			0.639
Regimen (with carboplatin)	0.008 (0.76)	1.008	0.992	0.226	4.505
Regimen (with dual HER2 blockade)	0.818 (0.97)	2.266	0.401	0.336	15.290
Constant	−1.968 (0.84)	0.140	0.06

Notes. ⁢.